Finanzierung
Forscher/in: Aintzane Zabaleta Azpiroz
10 Finanzierungen - 1.069.932€
2025
2021
-
Evaluation of the therapeutic efficacy of BCMA-targeted cost
euro 145.210,00
2020
-
Understanding the Alterations in the Bone Marrow Microenviro
euro 273.000,00
2019
-
Evaluation of the therapeutic efficacy of a compound in MM
euro 120.300,00
-
MECHANISM OF ACTION ANTI-CD38 IN MM AND AML
euro 91.200,00
-
Amyloidosis antibodies project
euro 19.384,00
-
Evaluation of TriNKET in BMA samples from MM patients
euro 96.600,00
-
Fibroblast Activation Factor (FAP) in Amyloidosis and MM
euro 103.260,00
2018
-
Inmunomonitorización de nueva generación en mieloma múltiple
euro 164.258,00